trihexyphenidyl has been researched along with Anton Syndrome in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Transient, postictal cortical blindness is a rare adverse effect of electroconvulsive therapy (ECT)." | 1.38 | Continuation of ECT after recovery from transient, ECT-induced, postictal cortical blindness. ( Andrade, C; Bambole, V; Bang, A; Shah, N; Sonavane, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sonavane, S | 1 |
| Bambole, V | 1 |
| Bang, A | 1 |
| Shah, N | 1 |
| Andrade, C | 1 |
1 other study available for trihexyphenidyl and Anton Syndrome
| Article | Year |
|---|---|
Continuation of ECT after recovery from transient, ECT-induced, postictal cortical blindness.
Topics: Adolescent; Anti-Dyskinesia Agents; Antipsychotic Agents; Atropine; Benzodiazepines; Blindness, Cort | 2012 |